Mitral Regurgitation Treatment: Understanding Your Surgery Options Beyond Repair vs. Replacement

Why Mitral Regurgitation Treatment Decisions Are More Complex Than You Have Been Told

If you have been diagnosed with significant mitral regurgitation, you have likely heard one question repeated: repair or replacement? It is a fair question, and I have written about the general comparison elsewhere on this site. But after performing hundreds of mitral valve operations, I can tell you that the real decision tree is more nuanced than a simple binary choice.

The mitral valve sits between your left atrium and left ventricle. When it leaks — when blood flows backward instead of forward — your heart has to work harder to deliver adequate circulation. Over time, untreated severe mitral regurgitation leads to heart enlargement, atrial fibrillation, pulmonary hypertension, and heart failure. The good news is that we have more effective mitral valve surgery options today than at any point in the history of cardiac surgery. The challenge is matching the right option to the right patient.

This article is not a repeat of a basic repair-versus-replacement overview. Instead, I want to walk you through the factors that actually shape the surgical plan — the things your surgeon is weighing behind the scenes — so you can be a more informed participant in your own care.

What Causes Your Mitral Regurgitation Matters More Than You Think

Not all mitral regurgitation is created equal. The cause of the leak is one of the most important variables in selecting the right mitral regurgitation treatment, and it is something patients are rarely educated about in enough detail.

Degenerative Mitral Regurgitation

This is the most common reason for mitral valve surgery in the United States. The valve tissue itself is abnormal — often due to myxomatous degeneration (sometimes called Barlow disease) or fibroelastic deficiency. A chord may have ruptured, or a leaflet is prolapsing into the atrium. In these cases, the valve structure is the primary problem, and the heart muscle is typically still healthy.

For degenerative disease, repair is strongly preferred over replacement. ACC/AHA guidelines give a Class I recommendation for mitral valve repair in severe degenerative mitral regurgitation when performed at experienced centers. Repair preserves your native valve, avoids lifelong blood thinners (in most cases), and is associated with better long-term survival. Studies from large referral centers show that experienced surgeons can repair more than 95% of degenerative mitral valves, with durability rates exceeding 90% at 15 to 20 years.

The critical word in that paragraph is experienced. Surgeon and center volume matter enormously here, and I will come back to that point.

Functional (Secondary) Mitral Regurgitation

In functional MR, the valve leaflets are structurally normal, but the heart itself has remodeled — usually from coronary artery disease or dilated cardiomyopathy — pulling the leaflets apart so they no longer close properly. The leak is a symptom of a bigger problem.

This is where treatment decisions become genuinely difficult. Repair in functional MR has a meaningful recurrence rate — some studies report moderate or severe MR returning in 30% to 60% of patients within a few years after ring annuloplasty alone. Replacement with chordal preservation can offer a more durable correction of the regurgitation but comes with the trade-offs of a prosthetic valve. There is active debate in the surgical literature, and the CTSN trial published in the New England Journal of Medicine showed that replacement led to a lower rate of recurrent MR compared to repair in patients with severe ischemic mitral regurgitation, with no significant difference in survival or left ventricular remodeling at two years.

If you have been told you have functional mitral regurgitation, the right treatment depends heavily on your ventricular function, the degree of remodeling, whether revascularization is also needed, and the specifics of your valve anatomy. This is exactly the kind of scenario where getting a second opinion can be pivotal.

Rheumatic and Other Etiologies

Rheumatic mitral valve disease, endocarditis, and certain congenital abnormalities can also cause significant mitral regurgitation or stenosis. Rheumatic disease often damages leaflets and the subvalvular apparatus so extensively that repair is not feasible, making replacement the more reliable option. These cases require careful individual assessment.

The Full Spectrum of Mitral Valve Surgery Options

When patients hear "mitral valve surgery," they often picture only one scenario: open-heart surgery through a full sternotomy. But the landscape is broader than that.

Conventional Mitral Valve Repair

This remains the gold standard for degenerative mitral regurgitation. Techniques include leaflet resection, neochord implantation using ePTFE sutures, annuloplasty ring placement, and commissuroplasty. A skilled mitral valve surgeon selects from these techniques based on what the valve looks like in the operating room. The goal is a durable repair that restores full leaflet coaptation without creating stenosis.

Mitral Valve Replacement

When repair is not feasible or not durable — as in some cases of functional MR, rheumatic disease, or heavily calcified valves — replacement is the appropriate choice. Mechanical valves are extremely durable but require lifelong warfarin. Bioprosthetic valves avoid the need for long-term anticoagulation but have a finite lifespan, typically 10 to 20 years depending on patient age and other factors. Whenever possible, preserving the subvalvular apparatus (chords and papillary muscles) during replacement helps maintain ventricular geometry and function.

Minimally Invasive and Robotic Approaches

Many mitral valve operations can now be performed through small right thoracotomy incisions or with robotic assistance, avoiding a full sternotomy. These approaches can reduce blood loss, shorten hospital stays, and speed recovery. However, they require significant surgical expertise and are not appropriate for every patient. The quality of the valve repair or replacement itself should never be compromised for the sake of a smaller incision.

Transcatheter Mitral Valve Interventions

The MitraClip (and newer transcatheter edge-to-edge repair devices) offers a catheter-based option for patients who are too high risk for conventional surgery. The COAPT trial demonstrated significant mortality and heart failure hospitalization benefits for MitraClip in carefully selected patients with functional MR on maximally tolerated medical therapy. However, transcatheter repair generally does not reduce MR as completely as surgical repair, and it is not a substitute for surgery in patients who are good operative candidates.

Transcatheter mitral valve replacement is also under active investigation in clinical trials but is not yet widely available outside of specialized centers.

How the Decision Is Actually Made: Factors Your Surgical Team Weighs

Here is what goes into a thoughtful recommendation for mitral regurgitation treatment — the factors I evaluate when reviewing a case:

• Etiology of MR: Degenerative, functional, rheumatic, or other. This is foundational.
• Valve anatomy: Which leaflet segments are involved? Is there calcification? Is the annulus dilated? Detailed echocardiographic assessment (ideally transesophageal) is essential.
• Left ventricular function and dimensions: A dilated, weakened ventricle changes the calculus significantly. Timing of surgery before irreversible ventricular damage is critical.
• Symptoms and functional status: Guidelines support surgery for severe MR even in asymptomatic patients if certain echocardiographic thresholds are met (e.g., LV ejection fraction dropping below 60% or LV end-systolic dimension reaching 40 mm or greater).
• Concomitant cardiac disease: Does the patient also need coronary bypass? Aortic valve surgery? Atrial fibrillation ablation? Combined procedures are common and influence the surgical approach.
• Patient age and comorbidities: A 50-year-old and an 82-year-old with the same valve lesion may receive very different recommendations. Our free cardiac surgery risk calculator can help you understand your estimated operative risk.
• Surgeon and center expertise: This is not a soft factor. It is one of the hardest predictors of outcome. The Society of Thoracic Surgeons reports that mitral valve repair rates vary dramatically across institutions — from under 50% at low-volume centers to over 95% at experienced referral centers. If your surgeon tells you the valve cannot be repaired, it may mean the valve truly cannot be repaired — or it may mean that particular surgeon cannot repair it. These are not the same thing.

When to Question the Plan: Red Flags and the Value of a Second Opinion

I want to be direct about this. Most cardiac surgeons are skilled, conscientious professionals. But mitral valve surgery outcomes are volume-dependent, and the stakes are high. Here are situations where I strongly recommend seeking an independent review:

• You have been told your degenerative mitral valve cannot be repaired, especially if the assessment was made at a center that does not perform high volumes of mitral repair.
• You have functional MR and are unsure whether repair, replacement, or medical management is the best path.
• You have been offered MitraClip but are not certain whether you might be a candidate for surgical repair, which generally provides a more complete correction.
• You are asymptomatic and have been told to "watch and wait" — but your echocardiographic parameters suggest the window for optimal surgical timing may be closing.
• You have been quoted an operative risk that seems high and want to verify it independently.

A second opinion does not mean you distrust your doctor. It means you are taking your life seriously. In my experience reviewing cases for WhiteGloveMD, a meaningful percentage of patients receive a revised or refined recommendation — sometimes involving a completely different surgical strategy. You can learn more about how our review process works.

Practical Advice for Patients Facing Mitral Valve Surgery

If you are actively weighing mitral valve surgery options, here are things I would tell you if you were sitting in my office:

• Get a transesophageal echocardiogram (TEE) if you have not had one. Transthoracic echo is a good screening tool, but TEE provides the detailed valve anatomy that drives surgical planning.
• Ask your surgeon their personal mitral valve repair rate. For degenerative disease, you want to hear a number above 90%. If they cannot or will not answer, that is informative.
• Ask about the surgical approach. Not because minimally invasive is always better, but because the answer will tell you about the surgeon's experience and how they think about your case.
• Understand the timing. Surgery performed before the heart dilates and weakens produces the best long-term outcomes. Waiting too long is one of the most common — and most avoidable — mistakes in mitral valve disease management.
• Bring a family member to your surgical consultation. Two sets of ears are better than one, and having someone to discuss the information with afterward is invaluable.

If you are facing a decision about mitral regurgitation treatment and want clarity about whether repair, replacement, or a catheter-based intervention is right for your specific anatomy and clinical situation, a WhiteGloveMD second opinion can help you move forward with confidence. Our reviews are conducted by board-certified cardiac surgeons using your actual medical records, imaging, and test results — not generic advice. Start your review today and know that the plan you choose is the right one for you.